Skip to main content

Table 1 Clinical characteristics of study patients

From: Tryptase as a marker of severity of aortic valve stenosis

Sex/age, years MACE-patients Non-MACE patients
M/85 F/58 F/53 F/72 F/77
Clinical history
 Hypertension Yes Yes Yes Yes Yes
 Hypercolesterolemia No Yes No Yes Yes
 Currently smoking Yes No No No No
 Diabetes mellitus No Yes No No No
 Obesity No No No No Yes
 COPD Yes No No No No
Left ventricle ejection fraction during index hospitalization
 Ejection fraction (%) 30 58 56 40 60
 Mean transvalvular gradient (mmHg) 70 75 70 65 65
Diagnostic findings
 Tryptase, ng/ml 10.9 11.7 9.32 5.69 5.58
 CRP, mg/dl 3.2 0.8 0.2 0.3 1.1
 hsTnT, ng/l 49.5 8.0 7.9 40 7.2
 Serum triglycerides, mg/dl 117 189 150 176 68
 HDL cholesterol, mg/dl 32 40 38 37 72
 LDL cholesterol, mg/dl 90 97 100 116 89
 Plasma glucose, mg/dl 119 181 104 87 114
Major cardiovascular events Sudden death STEACS STEACS None None
  1. STEACS ST elevation acute coronary syndrome, COPD Chronic obstructive pulmonary disease, CRP C-reactive protein, hsTnT high-sensitivity cardiac troponin T, HDL high-density lipoprotein, LDL low-density lipoprotein, MACE major cardiovascular events